Al-18F mark fusion peptide and application thereof

A label fusion, al-18f technology, applied in the biological field, can solve the problems of pharmaceutical, inconvenient transportation, increased use cost, clinical application obstacles, etc., to improve probe concentration, improve specificity, and improve target/non-target The effect of target ratio

Inactive Publication Date: 2014-03-05
THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIV
View PDF3 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

in addition, 11 The half-life of C isotope is relatively short, which causes inconvenient links such as pharma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Al-18F mark fusion peptide and application thereof
  • Al-18F mark fusion peptide and application thereof
  • Al-18F mark fusion peptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0035] Example 1

[0036] (1) Preparation of NOTA-PEG-RGDyK-Lys-Ac-A7R:

[0037] The reaction formula is as follows:

[0038]

[0039] Specifically: RGDyK-Lys-Ac-A7R can be purchased at home and abroad (Hangzhou Zhongpi Biochemical Co., Ltd.). Dissolve [2-[2-(fluorenylmethoxycarbonyl-amino)ethoxy]ethoxy]acetic acid in 1mL DMF (dimethylformamide), add NHS (N-hydroxysuccinimide, also called For HOSU) and DCC (bicyclohexyl carbodiimide), the reaction was stirred at room temperature for 2 hours. Add RGDyK-Lys-Ac-A7R to the above reaction solution, adjust the pH to 8.0-8.5 with DIEA (N,N-diisopropylethylamine), and stir at room temperature overnight. Add 3 mL of 0.5M NH4OAc buffer (pH=7.0) to the reaction solution and filter. The filtrate is separated and purified by HPLC. The fractions of the target product are collected, combined and lyophilized. The product is fluorenylmethoxycarbonyl-PEG-RGDyK-Lys-Ac- A7R adds 20% piperidine and reacts at room temperature for 30 minutes to remove ...

Example Embodiment

[0047] Example 2

[0048] This example is a comparative example, and the comparative object is [Al 18 F]NOTA-PEG-RGDyK, the structural formula is as follows:

[0049]

[0050] The preparation method is as follows:

[0051] (1) RGDyK can be purchased at home and abroad. Dissolve [2-[2-(fluorenylmethoxycarbonyl-amino)ethoxy]ethoxy]acetic acid in 1mL DMF (dimethylformamide), add NHS (N-hydroxysuccinimide, also called For HOSU) and DCC (bicyclohexyl carbodiimide), the reaction was stirred at room temperature for 2 hours. Add RGDyK to the above reaction solution, adjust the pH to 8.0-8.5 with DIEA (N,N-diisopropylethylamine), and stir at room temperature overnight. Add 3mL 0.5M NH4OAc buffer (pH=7.0) to the reaction solution and filter. The filtrate is separated and purified by HPLC. The fractions of the target product are collected, combined and lyophilized. The product fluorenylmethoxycarbonyl-PEG-RGDyK is added with 20% piperidine React at room temperature for 30 minutes to remove ...

Example Embodiment

[0056] Example 3

[0057] This example is a comparative example, and the comparative object is [Al 18 F]NOTA-PEG3-A7R, the structural formula is as follows:

[0058]

[0059] (1) A7R can be purchased at home and abroad. Dissolve [2-[2-(fluorenylmethoxycarbonyl-amino)ethoxy]ethoxy]acetic acid in 1mL DMF (dimethylformamide), add NHS (N-hydroxysuccinimide, also called For HOSU) and DCC (bicyclohexyl carbodiimide), the reaction was stirred at room temperature for 2 hours. Add ATWLPPR to the above reaction solution, adjust the pH to 8.0-8.5 with DIEA (N,N-diisopropylethylamine), and stir at room temperature overnight. Add 3mL 0.5M NH4OAc buffer (pH=7.0) to the reaction solution and filter. The filtrate is separated and purified by HPLC. The fractions of the target product are collected, combined and freeze-dried. The product fluorenylmethoxycarbonyl-PEG-A7R is added with 20% piperidine React at room temperature for 30 minutes to remove the fluorenylmethyloxycarbonyl group, and then a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an Al-18F mark fusion peptide and an application thereof. The Al-18F mark fusion peptide comprises glioma specific targeted polypeptides cRGDyK and A7R connected together. The preparation method comprises the following steps: (1) preparing NOTA-PEG-RGDyK-Lys-Ac-A7R; (3) preparing 18F physiological saline liquor; (3) preparing [Al18F]NOTA-PEG-RGDyK-Lys-Ac-A7R; and (4) purifying the prepared [Al18F]NOTA-PEG-RGDyK-Lys-Ac-A7R to obtain the Al-18F mark fusion peptide. The Al-18F mark fusion peptide disclosed by the invention comprises glioma specific targeted polypeptides cRGDyK and A7R connected together, and the specificity of the fusion peptide on glioma is further improved by means of different targeted biological characteristics.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to an Al- 18 F-labeled fusion peptide and its application. Background technique [0002] Glioma is the most common primary intracranial tumor, accounting for about 40-60% of all intracranial tumors, and has the characteristics of high recurrence rate, high mortality rate, and low cure rate. One of the main reasons is that most malignant gliomas grow infiltratingly and have unclear borders with the surrounding brain tissue. Currently, it is difficult to accurately determine the extent of the tumor using imaging techniques in clinical practice, and the evaluation of recurrence after treatment (surgery, radiotherapy and chemotherapy) is even more obvious. Insufficient, to increase the difficulty of clinical diagnosis and treatment. The establishment of specific imaging techniques for gliomas is of great significance for diagnosing malignant gliomas, guiding clinical treatment strategies ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K19/00C07K1/00
Inventor 吴华马玉飞陈皓鋆梁胜李业森彭添兴
Owner THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap